The rate of incidence of CD5 positivity is drastically decreased across the other subtypes of B-cell NHLs; however, the role of CD5 as a prognostic marker in these cancers has been extensively explored. The gene discussed is CD5; the disease is B-cell non-Hodgkin lymphoma.